Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Melanoma. A key objective of DelveInsights report is to establish the understanding for API Manufacturers for marketed and Phase III ... Read more

Melanoma is one of the deadliest forms of skin cancer that occurs when unrepaired DNA damage to skin cells triggers mutations that lead to uncontrolled growth and spread. While early-stage melanoma is generally curable through surgical removal of the tumor, advanced or metastatic melanoma remains an aggressive disease that has historically been difficult to effectively treat. However, there have been significant advancements in metastatic melanoma therapeutics over the past decade that are ... Read more